Oberoi Realty Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 24, 2025, 9:25 pm

Competitors of Oberoi Realty Ltd

All Competitor Stocks of Oberoi Realty Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:15 am

Below is a detailed analysis of the quarterly data for Oberoi Realty Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,150.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,411.00 Cr. (Dec 2024) to 1,150.00 Cr., marking a decrease of 261.00 Cr..
• For Expenses, as of Mar 2025, the value is 532.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 555.00 Cr. (Dec 2024) to 532.00 Cr., marking a decrease of 23.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 618.00 Cr.. The value appears to be declining and may need further review. It has decreased from 856.00 Cr. (Dec 2024) to 618.00 Cr., marking a decrease of 238.00 Cr..
• For OPM %, as of Mar 2025, the value is 54.00%. The value appears to be declining and may need further review. It has decreased from 61.00% (Dec 2024) to 54.00%, marking a decrease of 7.00%.
• For Other Income, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Dec 2024) to 63.00 Cr., marking an increase of 11.00 Cr..
• For Interest, as of Mar 2025, the value is 80.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 75.00 Cr. (Dec 2024) to 80.00 Cr., marking an increase of 5.00 Cr..
• For Depreciation, as of Mar 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.00 Cr. (Dec 2024) to 24.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 577.00 Cr.. The value appears to be declining and may need further review. It has decreased from 810.00 Cr. (Dec 2024) to 577.00 Cr., marking a decrease of 233.00 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Dec 2024) to 25.00%, marking an increase of 1.00%.
• For Net Profit, as of Mar 2025, the value is 433.00 Cr.. The value appears to be declining and may need further review. It has decreased from 618.00 Cr. (Dec 2024) to 433.00 Cr., marking a decrease of 185.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 11.91. The value appears to be declining and may need further review. It has decreased from 17.01 (Dec 2024) to 11.91, marking a decrease of 5.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:36 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:36 am

Below is a detailed analysis of the balance sheet data for Oberoi Realty Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 364.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 364.00 Cr..
• For Reserves, as of Mar 2025, the value is 15,341.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,481.00 Cr. (Mar 2024) to 15,341.00 Cr., marking an increase of 1,860.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3,300.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,495.00 Cr. (Mar 2024) to 3,300.00 Cr., marking an increase of 805.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3,710.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,293.00 Cr. (Mar 2024) to 3,710.00 Cr., marking an increase of 417.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 22,715.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,633.00 Cr. (Mar 2024) to 22,715.00 Cr., marking an increase of 3,082.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4,685.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,053.00 Cr. (Mar 2024) to 4,685.00 Cr., marking an increase of 1,632.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,604.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,705.00 Cr. (Mar 2024) to 1,604.00 Cr., marking a decrease of 1,101.00 Cr..
• For Investments, as of Mar 2025, the value is 2,535.00 Cr.. The value appears strong and on an upward trend. It has increased from 818.00 Cr. (Mar 2024) to 2,535.00 Cr., marking an increase of 1,717.00 Cr..
• For Other Assets, as of Mar 2025, the value is 13,891.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,057.00 Cr. (Mar 2024) to 13,891.00 Cr., marking an increase of 834.00 Cr..
• For Total Assets, as of Mar 2025, the value is 22,715.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,633.00 Cr. (Mar 2024) to 22,715.00 Cr., marking an increase of 3,082.00 Cr..

Notably, the Reserves (15,341.00 Cr.) exceed the Borrowings (3,300.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Oberoi Realty Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 61.21. This value is within the healthy range. It has increased from 52.99 (Mar 24) to 61.21, marking an increase of 8.22.
• For Diluted EPS (Rs.), as of Mar 25, the value is 61.21. This value is within the healthy range. It has increased from 52.99 (Mar 24) to 61.21, marking an increase of 8.22.
• For Cash EPS (Rs.), as of Mar 25, the value is 63.43. This value is within the healthy range. It has increased from 54.05 (Mar 24) to 63.43, marking an increase of 9.38.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 431.92. It has increased from 380.76 (Mar 24) to 431.92, marking an increase of 51.16.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 431.92. It has increased from 380.76 (Mar 24) to 431.92, marking an increase of 51.16.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 145.39. It has increased from 123.65 (Mar 24) to 145.39, marking an increase of 21.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 90.51. This value is within the healthy range. It has increased from 75.16 (Mar 24) to 90.51, marking an increase of 15.35.
• For PBIT / Share (Rs.), as of Mar 25, the value is 88.08. This value is within the healthy range. It has increased from 73.85 (Mar 24) to 88.08, marking an increase of 14.23.
• For PBT / Share (Rs.), as of Mar 25, the value is 80.78. This value is within the healthy range. It has increased from 67.84 (Mar 24) to 80.78, marking an increase of 12.94.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 61.00. This value is within the healthy range. It has increased from 52.74 (Mar 24) to 61.00, marking an increase of 8.26.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 61.21. This value is within the healthy range. It has increased from 52.99 (Mar 24) to 61.21, marking an increase of 8.22.
• For PBDIT Margin (%), as of Mar 25, the value is 62.25. This value is within the healthy range. It has increased from 60.78 (Mar 24) to 62.25, marking an increase of 1.47.
• For PBIT Margin (%), as of Mar 25, the value is 60.58. This value exceeds the healthy maximum of 20. It has increased from 59.72 (Mar 24) to 60.58, marking an increase of 0.86.
• For PBT Margin (%), as of Mar 25, the value is 55.56. This value is within the healthy range. It has increased from 54.87 (Mar 24) to 55.56, marking an increase of 0.69.
• For Net Profit Margin (%), as of Mar 25, the value is 41.95. This value exceeds the healthy maximum of 10. It has decreased from 42.65 (Mar 24) to 41.95, marking a decrease of 0.70.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 42.09. This value exceeds the healthy maximum of 20. It has decreased from 42.85 (Mar 24) to 42.09, marking a decrease of 0.76.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.17. This value is below the healthy minimum of 15. It has increased from 13.91 (Mar 24) to 14.17, marking an increase of 0.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.64. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 16.64, marking an increase of 0.23.
• For Return On Assets (%), as of Mar 25, the value is 9.78. This value is within the healthy range. It has decreased from 9.81 (Mar 24) to 9.78, marking a decrease of 0.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has increased from 0.15 (Mar 24) to 0.18, marking an increase of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.24. It has increased from 0.23 (Mar 24) to 0.24, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 3.89 (Mar 24) to 4.34, marking an increase of 0.45.
• For Quick Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 1.65, marking an increase of 0.59.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 16.33. This value is below the healthy minimum of 20. It has increased from 15.09 (Mar 24) to 16.33, marking an increase of 1.24.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.71. This value is below the healthy minimum of 20. It has increased from 14.73 (Mar 24) to 15.71, marking an increase of 0.98.
• For Earning Retention Ratio (%), as of Mar 25, the value is 83.67. This value exceeds the healthy maximum of 70. It has decreased from 84.91 (Mar 24) to 83.67, marking a decrease of 1.24.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.29. This value exceeds the healthy maximum of 70. It has decreased from 85.27 (Mar 24) to 84.29, marking a decrease of 0.98.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 12.51 (Mar 24) to 12.41, marking a decrease of 0.10.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.36. This value is within the healthy range. It has decreased from 9.78 (Mar 24) to 9.36, marking a decrease of 0.42.
• For Enterprise Value (Cr.), as of Mar 25, the value is 61,780.95. It has increased from 55,310.30 (Mar 24) to 61,780.95, marking an increase of 6,470.65.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.69. This value exceeds the healthy maximum of 3. It has decreased from 12.30 (Mar 24) to 11.69, marking a decrease of 0.61.
• For EV / EBITDA (X), as of Mar 25, the value is 18.77. This value exceeds the healthy maximum of 15. It has decreased from 20.24 (Mar 24) to 18.77, marking a decrease of 1.47.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.25. This value exceeds the healthy maximum of 3. It has decreased from 11.92 (Mar 24) to 11.25, marking a decrease of 0.67.
• For Retention Ratios (%), as of Mar 25, the value is 83.66. This value exceeds the healthy maximum of 70. It has decreased from 84.90 (Mar 24) to 83.66, marking a decrease of 1.24.
• For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 3.87 (Mar 24) to 3.79, marking a decrease of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.25. This value exceeds the healthy maximum of 3. It has decreased from 11.92 (Mar 24) to 11.25, marking a decrease of 0.67.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness